Development of Chimeric Antigen Receptor-Redirected T Cell Therapy Targeting L1-Cam in Ovarian Cancer

Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-1-s1-p16
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2016English

Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma

International Journal of Hematology
Hematology
2020English

Targeting the Adenosine 2A Receptor Enhances Chimeric Antigen Receptor T Cell Efficacy

Journal of Clinical Investigation
Medicine
2017English

Advancing Chimeric Antigen Receptor T Cell Therapy With CRISPR/Cas9

Protein & Cell
BiochemistryBiotechnologyDrug DiscoveryCell BiologyMedicine
2017English

Cytokine Release Syndrome With Chimeric Antigen Receptor T Cell Therapy

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

394. McSP-Chimeric Antigen Receptor (CAR)-Redirected T Cells Target Multiple Solid Tumors

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Chimeric Antigen Receptor T Cell Targeting B Cell Maturation Antigen Immunotherapy Is Promising for Multiple Myeloma

Annals of Hematology
MedicineHematology
2019English

Cytotoxic Function of Chimeric Antigen Receptor (CAR) T Cells Redirected by Anti-Muci Nanobody

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Molecular Pathways: Breaking the Epithelial Cancer Barrier for Chimeric Antigen Receptor and T-Cell Receptor Gene Therapy

Clinical Cancer Research
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy